ARDELYX INC. - COMMON STOCK
9.2200
06-May-24 14:18:05
15 minutes delayed
Stocks
+0.5000
+5.73%
Today's range
8.6100 - 9.2700
ISIN
N/A
Source
NASDAQ
-
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
17 Oct 2023 19:01:06 By Nasdaq GlobeNewswire
-
13 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
28 Sep 2023 08:02:00 By Nasdaq GlobeNewswire
-
Tenapanor for Hyperphosphatemia Approved in Japan
25 Sep 2023 04:15:13 By Nasdaq GlobeNewswire
-
11 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
07 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
02 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
27 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
26 Jul 2023 07:55:00 By Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
20 Jul 2023 16:05:00 By Nasdaq GlobeNewswire
-
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
13 Jul 2023 08:00:01 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
29 Jun 2023 16:09:08 By Nasdaq GlobeNewswire
-
05 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
31 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
23 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
17 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
15 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
09 May 2023 08:00:02 By Nasdaq GlobeNewswire